Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus | 22 | 2019 | 390 | 3.330 |
Why?
|
| Diabetes Mellitus, Type 2 | 18 | 2019 | 1438 | 2.360 |
Why?
|
| Clinical Competence | 5 | 2019 | 329 | 1.450 |
Why?
|
| Blood Glucose Self-Monitoring | 6 | 2013 | 23 | 1.380 |
Why?
|
| Family Practice | 5 | 2020 | 49 | 1.360 |
Why?
|
| Curriculum | 3 | 2018 | 203 | 1.160 |
Why?
|
| Blood Glucose | 8 | 2013 | 484 | 1.120 |
Why?
|
| Health Literacy | 4 | 2018 | 27 | 1.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 7 | 2019 | 317 | 1.070 |
Why?
|
| Patient Education as Topic | 6 | 2018 | 245 | 1.050 |
Why?
|
| Attitude to Health | 3 | 2020 | 137 | 0.980 |
Why?
|
| Self Care | 8 | 2016 | 97 | 0.980 |
Why?
|
| European Continental Ancestry Group | 11 | 2014 | 1076 | 0.940 |
Why?
|
| Humans | 57 | 2021 | 32323 | 0.900 |
Why?
|
| Hypertension | 4 | 2017 | 983 | 0.880 |
Why?
|
| Female | 41 | 2020 | 19969 | 0.850 |
Why?
|
| Primary Health Care | 4 | 2021 | 232 | 0.840 |
Why?
|
| Antihypertensive Agents | 2 | 2017 | 365 | 0.840 |
Why?
|
| Middle Aged | 32 | 2021 | 11848 | 0.750 |
Why?
|
| Hypoglycemic Agents | 4 | 2010 | 186 | 0.720 |
Why?
|
| Patient-Centered Care | 2 | 2016 | 75 | 0.710 |
Why?
|
| Male | 36 | 2020 | 19456 | 0.700 |
Why?
|
| Students, Medical | 3 | 2019 | 126 | 0.660 |
Why?
|
| Naloxone | 1 | 2021 | 32 | 0.660 |
Why?
|
| Aged | 28 | 2020 | 10259 | 0.640 |
Why?
|
| Ethnic Groups | 5 | 2016 | 450 | 0.630 |
Why?
|
| Mental Health Services | 1 | 2020 | 34 | 0.630 |
Why?
|
| African Americans | 9 | 2014 | 1335 | 0.600 |
Why?
|
| Obstetrics | 1 | 2019 | 25 | 0.590 |
Why?
|
| Pharmacists | 2 | 2017 | 20 | 0.590 |
Why?
|
| Islam | 1 | 2019 | 2 | 0.580 |
Why?
|
| Arabs | 1 | 2019 | 4 | 0.580 |
Why?
|
| Maternal Health Services | 1 | 2019 | 5 | 0.580 |
Why?
|
| Diabetic Neuropathies | 1 | 2019 | 28 | 0.580 |
Why?
|
| Refugees | 1 | 2019 | 10 | 0.580 |
Why?
|
| Adult | 16 | 2020 | 9267 | 0.580 |
Why?
|
| Patient Compliance | 5 | 2013 | 206 | 0.570 |
Why?
|
| Health Behavior | 5 | 2014 | 213 | 0.570 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 230 | 0.570 |
Why?
|
| Neuralgia | 1 | 2019 | 46 | 0.560 |
Why?
|
| Group Processes | 1 | 2018 | 12 | 0.540 |
Why?
|
| Cardiovascular Diseases | 5 | 2016 | 1159 | 0.530 |
Why?
|
| North Carolina | 12 | 2019 | 1300 | 0.520 |
Why?
|
| Education, Pharmacy, Continuing | 1 | 2017 | 2 | 0.520 |
Why?
|
| Education, Medical, Continuing | 2 | 2008 | 49 | 0.520 |
Why?
|
| Diabetes, Gestational | 2 | 2009 | 28 | 0.520 |
Why?
|
| Aged, 80 and over | 16 | 2020 | 3899 | 0.510 |
Why?
|
| Program Development | 1 | 2017 | 93 | 0.500 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 242 | 0.490 |
Why?
|
| Insulin | 2 | 2010 | 359 | 0.480 |
Why?
|
| Prenatal Care | 1 | 2016 | 54 | 0.470 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 212 | 0.470 |
Why?
|
| Anticoagulants | 1 | 2017 | 122 | 0.470 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2017 | 216 | 0.470 |
Why?
|
| Cross-Sectional Studies | 12 | 2014 | 1485 | 0.460 |
Why?
|
| Patient Participation | 1 | 2016 | 90 | 0.460 |
Why?
|
| Practice Guidelines as Topic | 3 | 2017 | 395 | 0.450 |
Why?
|
| Blood Pressure | 5 | 2017 | 866 | 0.440 |
Why?
|
| Diabetic Angiopathies | 2 | 2013 | 150 | 0.420 |
Why?
|
| Rural Population | 8 | 2014 | 217 | 0.420 |
Why?
|
| Cultural Characteristics | 1 | 2014 | 14 | 0.410 |
Why?
|
| Students, Health Occupations | 1 | 2013 | 7 | 0.380 |
Why?
|
| Dietary Fats | 1 | 2013 | 99 | 0.370 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2018 | 75 | 0.370 |
Why?
|
| Counseling | 1 | 2013 | 94 | 0.370 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2014 | 158 | 0.360 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2011 | 3 | 0.350 |
Why?
|
| Pregnancy | 4 | 2019 | 964 | 0.330 |
Why?
|
| Cohort Studies | 6 | 2020 | 1840 | 0.320 |
Why?
|
| Hyperglycemia | 1 | 2010 | 85 | 0.310 |
Why?
|
| United States | 9 | 2014 | 4079 | 0.300 |
Why?
|
| Risk Factors | 11 | 2017 | 3940 | 0.300 |
Why?
|
| Academic Medical Centers | 2 | 2008 | 161 | 0.290 |
Why?
|
| Research Design | 2 | 2008 | 316 | 0.290 |
Why?
|
| Qualitative Research | 5 | 2019 | 180 | 0.280 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2008 | 5 | 0.270 |
Why?
|
| Disease Management | 3 | 2014 | 129 | 0.270 |
Why?
|
| Minority Groups | 3 | 2016 | 81 | 0.270 |
Why?
|
| Dietary Carbohydrates | 1 | 2008 | 21 | 0.270 |
Why?
|
| Faculty, Medical | 1 | 2008 | 76 | 0.250 |
Why?
|
| Ambulatory Care | 2 | 2018 | 111 | 0.250 |
Why?
|
| Education, Medical, Graduate | 1 | 2007 | 130 | 0.240 |
Why?
|
| Hispanic Americans | 3 | 2007 | 772 | 0.240 |
Why?
|
| Indians, North American | 6 | 2013 | 75 | 0.240 |
Why?
|
| Coronary Disease | 1 | 2007 | 226 | 0.240 |
Why?
|
| Hyperlipidemias | 2 | 2005 | 61 | 0.230 |
Why?
|
| Cholesterol, LDL | 1 | 2005 | 170 | 0.210 |
Why?
|
| Mass Screening | 2 | 2009 | 256 | 0.210 |
Why?
|
| Obesity | 3 | 2016 | 1111 | 0.210 |
Why?
|
| Exercise | 3 | 2016 | 605 | 0.210 |
Why?
|
| Physician-Patient Relations | 2 | 2018 | 179 | 0.210 |
Why?
|
| Socioeconomic Factors | 3 | 2014 | 388 | 0.200 |
Why?
|
| Absorptiometry, Photon | 1 | 2002 | 98 | 0.180 |
Why?
|
| Reproducibility of Results | 3 | 2013 | 757 | 0.180 |
Why?
|
| Osteoporosis | 1 | 2002 | 51 | 0.170 |
Why?
|
| Harm Reduction | 1 | 2021 | 15 | 0.170 |
Why?
|
| Narcotic Antagonists | 1 | 2021 | 47 | 0.160 |
Why?
|
| Age Factors | 4 | 2013 | 1179 | 0.160 |
Why?
|
| Serbia | 1 | 2019 | 4 | 0.150 |
Why?
|
| Prospective Studies | 2 | 2021 | 2319 | 0.150 |
Why?
|
| Physician Assistants | 2 | 2013 | 39 | 0.150 |
Why?
|
| Appointments and Schedules | 1 | 2019 | 21 | 0.150 |
Why?
|
| Risk Reduction Behavior | 2 | 2016 | 117 | 0.150 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2011 | 548 | 0.140 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 251 | 0.140 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 167 | 0.140 |
Why?
|
| Education, Medical | 1 | 2019 | 69 | 0.140 |
Why?
|
| Adaptation, Psychological | 1 | 2019 | 134 | 0.130 |
Why?
|
| Clinical Clerkship | 1 | 2018 | 39 | 0.130 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 854 | 0.130 |
Why?
|
| South Carolina | 1 | 2017 | 29 | 0.130 |
Why?
|
| Tennessee | 1 | 2017 | 101 | 0.130 |
Why?
|
| Certification | 1 | 2017 | 29 | 0.130 |
Why?
|
| Frail Elderly | 1 | 2017 | 69 | 0.130 |
Why?
|
| Adolescent | 2 | 2020 | 3521 | 0.130 |
Why?
|
| Group Practice | 1 | 2016 | 3 | 0.120 |
Why?
|
| Administration, Cutaneous | 1 | 2017 | 116 | 0.120 |
Why?
|
| Models, Organizational | 1 | 2016 | 18 | 0.120 |
Why?
|
| Communication | 1 | 2018 | 129 | 0.120 |
Why?
|
| Young Adult | 2 | 2020 | 2652 | 0.120 |
Why?
|
| Sex Factors | 3 | 2013 | 656 | 0.120 |
Why?
|
| Caloric Restriction | 1 | 2016 | 92 | 0.120 |
Why?
|
| Longitudinal Studies | 2 | 2019 | 760 | 0.110 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 312 | 0.110 |
Why?
|
| African Continental Ancestry Group | 2 | 2007 | 338 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 716 | 0.110 |
Why?
|
| Patient Selection | 1 | 2016 | 272 | 0.110 |
Why?
|
| Culture | 2 | 2012 | 34 | 0.110 |
Why?
|
| Electronic Health Records | 1 | 2016 | 179 | 0.110 |
Why?
|
| Linear Models | 2 | 2013 | 426 | 0.110 |
Why?
|
| Diabetes Complications | 2 | 2013 | 171 | 0.100 |
Why?
|
| Executive Function | 2 | 2012 | 52 | 0.100 |
Why?
|
| Fear | 1 | 2013 | 42 | 0.100 |
Why?
|
| Trust | 1 | 2013 | 43 | 0.100 |
Why?
|
| Faculty | 1 | 2013 | 14 | 0.100 |
Why?
|
| Patient Simulation | 1 | 2013 | 29 | 0.090 |
Why?
|
| Feedback | 1 | 2013 | 41 | 0.090 |
Why?
|
| Energy Intake | 1 | 2013 | 122 | 0.090 |
Why?
|
| Weight Gain | 1 | 2013 | 104 | 0.090 |
Why?
|
| Cognition | 2 | 2013 | 549 | 0.090 |
Why?
|
| Interpersonal Relations | 1 | 2012 | 58 | 0.090 |
Why?
|
| Program Evaluation | 1 | 2013 | 171 | 0.090 |
Why?
|
| Social Control, Informal | 1 | 2012 | 7 | 0.090 |
Why?
|
| Placebos | 1 | 2011 | 69 | 0.090 |
Why?
|
| Glycemic Index | 1 | 2011 | 14 | 0.090 |
Why?
|
| Interviews as Topic | 4 | 2013 | 195 | 0.080 |
Why?
|
| Body Weight | 1 | 2013 | 323 | 0.080 |
Why?
|
| Lipoproteins, LDL | 1 | 2011 | 99 | 0.080 |
Why?
|
| Narration | 1 | 2011 | 16 | 0.080 |
Why?
|
| Motor Activity | 1 | 2013 | 332 | 0.080 |
Why?
|
| Insurance Coverage | 1 | 2011 | 80 | 0.080 |
Why?
|
| Pharmacy Service, Hospital | 1 | 2010 | 11 | 0.080 |
Why?
|
| Professional Role | 1 | 2010 | 21 | 0.080 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 47 | 0.080 |
Why?
|
| Chi-Square Distribution | 2 | 2007 | 287 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2013 | 863 | 0.080 |
Why?
|
| Documentation | 1 | 2010 | 39 | 0.080 |
Why?
|
| Asian Americans | 2 | 2007 | 92 | 0.070 |
Why?
|
| Choice Behavior | 1 | 2010 | 84 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2010 | 267 | 0.070 |
Why?
|
| Staff Development | 1 | 2008 | 15 | 0.070 |
Why?
|
| Geography | 1 | 2007 | 30 | 0.070 |
Why?
|
| Safety | 1 | 2008 | 65 | 0.070 |
Why?
|
| Life Style | 1 | 2010 | 394 | 0.070 |
Why?
|
| Models, Educational | 1 | 2007 | 20 | 0.070 |
Why?
|
| Mexican Americans | 1 | 2007 | 52 | 0.070 |
Why?
|
| Hospitalization | 1 | 2010 | 476 | 0.060 |
Why?
|
| Lipid Metabolism | 1 | 2008 | 108 | 0.060 |
Why?
|
| Information Systems | 1 | 2006 | 9 | 0.060 |
Why?
|
| Nutrition Surveys | 1 | 2007 | 144 | 0.060 |
Why?
|
| Logistic Models | 2 | 2012 | 743 | 0.060 |
Why?
|
| Insulin, Long-Acting | 1 | 2006 | 3 | 0.060 |
Why?
|
| Odds Ratio | 1 | 2007 | 455 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2016 | 3410 | 0.060 |
Why?
|
| Pregnancy Outcome | 1 | 2006 | 86 | 0.060 |
Why?
|
| Social Justice | 1 | 2005 | 16 | 0.060 |
Why?
|
| Quality Indicators, Health Care | 1 | 2005 | 62 | 0.060 |
Why?
|
| Quality of Life | 2 | 2016 | 971 | 0.050 |
Why?
|
| Lipids | 1 | 2005 | 254 | 0.050 |
Why?
|
| Minerals | 1 | 2003 | 14 | 0.050 |
Why?
|
| Child | 1 | 2009 | 2445 | 0.050 |
Why?
|
| Vitamins | 1 | 2003 | 70 | 0.050 |
Why?
|
| Medicare | 1 | 2004 | 218 | 0.050 |
Why?
|
| Heel | 1 | 2002 | 7 | 0.040 |
Why?
|
| Alendronate | 1 | 2002 | 10 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2003 | 189 | 0.040 |
Why?
|
| Bone Density | 1 | 2002 | 169 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2005 | 1424 | 0.040 |
Why?
|
| Geriatric Assessment | 2 | 2012 | 335 | 0.040 |
Why?
|
| Depression | 2 | 2012 | 427 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2019 | 184 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2005 | 3613 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2019 | 229 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2016 | 33 | 0.030 |
Why?
|
| Community Health Services | 1 | 2016 | 47 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 191 | 0.030 |
Why?
|
| Poverty | 1 | 2016 | 105 | 0.030 |
Why?
|
| Overweight | 1 | 2016 | 252 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2005 | 478 | 0.030 |
Why?
|
| Weight Loss | 1 | 2016 | 410 | 0.020 |
Why?
|
| Medicine | 1 | 2013 | 36 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2013 | 47 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2005 | 773 | 0.020 |
Why?
|
| Family Relations | 1 | 2012 | 19 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2012 | 83 | 0.020 |
Why?
|
| Cross-Cultural Comparison | 1 | 2012 | 20 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2013 | 178 | 0.020 |
Why?
|
| Disabled Persons | 1 | 2012 | 100 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2012 | 72 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 2204 | 0.020 |
Why?
|
| Holistic Health | 1 | 2011 | 5 | 0.020 |
Why?
|
| Health Status | 1 | 2013 | 356 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2012 | 273 | 0.020 |
Why?
|
| Educational Status | 1 | 2012 | 168 | 0.020 |
Why?
|
| Incidence | 2 | 2005 | 1244 | 0.020 |
Why?
|
| Social Environment | 1 | 2011 | 75 | 0.020 |
Why?
|
| Social Support | 1 | 2012 | 181 | 0.020 |
Why?
|
| Continental Population Groups | 1 | 2012 | 228 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2011 | 139 | 0.020 |
Why?
|
| Aging | 1 | 2012 | 943 | 0.010 |
Why?
|
| Southeastern United States | 1 | 2005 | 75 | 0.010 |
Why?
|
| Morbidity | 1 | 2005 | 98 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2007 | 427 | 0.010 |
Why?
|
| Infection Control | 1 | 2003 | 26 | 0.010 |
Why?
|
| Prevalence | 1 | 2005 | 960 | 0.010 |
Why?
|
| Nutritional Status | 1 | 2003 | 73 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2003 | 567 | 0.010 |
Why?
|